189 related articles for article (PubMed ID: 36353639)
1. Research trends on clinical fecal microbiota transplantation: A biliometric analysis from 2001 to 2021.
Li Y; Ouyang Y; He C
Front Immunol; 2022; 13():991788. PubMed ID: 36353639
[TBL] [Abstract][Full Text] [Related]
2. Safety and preliminary efficacy of orally administered lyophilized fecal microbiota product compared with frozen product given by enema for recurrent Clostridium difficile infection: A randomized clinical trial.
Jiang ZD; Jenq RR; Ajami NJ; Petrosino JF; Alexander AA; Ke S; Iqbal T; DuPont AW; Muldrew K; Shi Y; Peterson C; Do KA; DuPont HL
PLoS One; 2018; 13(11):e0205064. PubMed ID: 30388112
[TBL] [Abstract][Full Text] [Related]
3. Fecal microbiota transplantation for treatment of recurrent C. difficile infection: An updated randomized controlled trial meta-analysis.
Hui W; Li T; Liu W; Zhou C; Gao F
PLoS One; 2019; 14(1):e0210016. PubMed ID: 30673716
[TBL] [Abstract][Full Text] [Related]
4. Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection: A Randomized Trial.
Kelly CR; Khoruts A; Staley C; Sadowsky MJ; Abd M; Alani M; Bakow B; Curran P; McKenney J; Tisch A; Reinert SE; Machan JT; Brandt LJ
Ann Intern Med; 2016 Nov; 165(9):609-616. PubMed ID: 27547925
[TBL] [Abstract][Full Text] [Related]
5. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
[TBL] [Abstract][Full Text] [Related]
6. Fecal Microbiota Transplantation (FMT) with Colonoscopy Is Superior to Enema and Nasogastric Tube While Comparable to Capsule for the Treatment of Recurrent Clostridioides difficile Infection: A Systematic Review and Meta-Analysis.
Ramai D; Zakhia K; Fields PJ; Ofosu A; Patel G; Shahnazarian V; Lai JK; Dhaliwal A; Reddy M; Chang S
Dig Dis Sci; 2021 Feb; 66(2):369-380. PubMed ID: 32166622
[TBL] [Abstract][Full Text] [Related]
7. Fecal microbiota transplantation for recurrent Clostridioides difficile infection.
Haber SL; Raney CRK; Larson TL; Lau JP
Am J Health Syst Pharm; 2019 Jun; 76(13):935-942. PubMed ID: 31361890
[TBL] [Abstract][Full Text] [Related]
8. The Evolving Landscape of Fecal Microbial Transplantation.
Shao T; Hsu R; Hacein-Bey C; Zhang W; Gao L; Kurth MJ; Zhao H; Shuai Z; Leung PSC
Clin Rev Allergy Immunol; 2023 Oct; 65(2):101-120. PubMed ID: 36757537
[TBL] [Abstract][Full Text] [Related]
9. Key determinants of success in fecal microbiota transplantation: From microbiome to clinic.
Porcari S; Benech N; Valles-Colomer M; Segata N; Gasbarrini A; Cammarota G; Sokol H; Ianiro G
Cell Host Microbe; 2023 May; 31(5):712-733. PubMed ID: 37167953
[TBL] [Abstract][Full Text] [Related]
10. Oral, frozen fecal microbiota transplant (FMT) capsules for recurrent Clostridium difficile infection.
Youngster I; Mahabamunuge J; Systrom HK; Sauk J; Khalili H; Levin J; Kaplan JL; Hohmann EL
BMC Med; 2016 Sep; 14(1):134. PubMed ID: 27609178
[TBL] [Abstract][Full Text] [Related]
11. Fecal Microbiome Transplantation for Recurrent Clostridioides difficile Infection: Treatment Efficacy, Short and Long-term Follow-up Results from Consecutive Case Series.
Urbonas T; Ianiro G; Gedgaudas R; Sabanas P; Urba M; Kiudelis V; Kiudelis G; Petkevicius V; Vitkauskiene A; Cammarota G; Gasbarrini A; Kupcinskas J
J Gastrointestin Liver Dis; 2021 Dec; 30(4):470-476. PubMed ID: 34752587
[TBL] [Abstract][Full Text] [Related]
12. [Fecal Microbiota Transfer (FMT) in Children and Adolescents - Review and statement by the GPGE microbiome working group].
Joachim A; Schwerd T; Hölz H; Sokollik C; Konrad LA; Jordan A; Lanzersdorfer R; Schmidt-Choudhury A; Hünseler C; Adam R
Z Gastroenterol; 2022 Jun; 60(6):963-969. PubMed ID: 35533688
[TBL] [Abstract][Full Text] [Related]
13. Fecal Microbiota Transplantation Research over the Past Decade: Current Status and Trends.
Hao S; Yang S; Zhang N; Cheng H
Can J Infect Dis Med Microbiol; 2023; 2023():6981721. PubMed ID: 36654766
[TBL] [Abstract][Full Text] [Related]
14. Fecal Microbiota Transplantation Across the Lifespan: Balancing Efficacy, Safety, and Innovation.
Gulati AS; Nicholson MR; Khoruts A; Kahn SA
Am J Gastroenterol; 2023 Mar; 118(3):435-439. PubMed ID: 36580630
[TBL] [Abstract][Full Text] [Related]
15. Faecal microbiota transplantation in the treatment of recurrent intestinal Clostridioides difficile infection - a ten-year single-center experience.
Pipek B; Valentová H; Fojtík P; Urban O
Cas Lek Cesk; 2022; 161(3-4):126-130. PubMed ID: 36100450
[TBL] [Abstract][Full Text] [Related]
16. Superiority of Higher-Volume Fresh Feces Compared to Lower-Volume Frozen Feces in Fecal Microbiota Transplantation for Recurrent Clostridioides Difficile Colitis.
Agarwal A; Maheshwari A; Verma S; Arrup D; Phillips L; Vinayek R; Nair P; Hagan M; Dutta S
Dig Dis Sci; 2021 Jun; 66(6):2000-2004. PubMed ID: 32656604
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Efficacy and Safety of Fecal Microbiota Transplantation for Treatment of Recurrent Clostridioides difficile Infection.
Perler BK; Chen B; Phelps E; Allegretti JR; Fischer M; Ganapini V; Krajiceck E; Kumar V; Marcus J; Nativ L; Kelly CR
J Clin Gastroenterol; 2020 Sep; 54(8):701-706. PubMed ID: 32011405
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of fecal microbiota transplant for the treatment of Clostridioides difficile diarrhea: a systematic review and meta-analysis.
Pomares Bascuñana RÁ; Veses V; Sheth CC
Lett Appl Microbiol; 2021 Aug; 73(2):149-158. PubMed ID: 33864273
[TBL] [Abstract][Full Text] [Related]
19. Alteration of gut microbial composition associated with the therapeutic efficacy of fecal microbiota transplantation in Clostridium difficile infection.
Lee PC; Chang TE; Wang YP; Lee KC; Lin YT; Chiou JJ; Huang CW; Yang UC; Li FY; Huang HC; Wu CY; Huang YH; Hou MC
J Formos Med Assoc; 2022 Sep; 121(9):1636-1646. PubMed ID: 34836663
[TBL] [Abstract][Full Text] [Related]
20. The Route to Palatable Fecal Microbiota Transplantation.
Fadda HM
AAPS PharmSciTech; 2020 Apr; 21(3):114. PubMed ID: 32296975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
